Equity RiskCardiff Oncology burns $12M quarterly with only 5 quarters of cash remainingViaNews Editorial Team (Markets)•Mar 7, 2026
Earnings & Corporate EventsCardiff Oncology CEO Faces FDA Trial Endpoint Risk as Q1 Data NearsViaNews Editorial Team (Markets)•Mar 7, 2026